Early stage synthetic biology company creating a portfolio of customized (patented) high performance, gene-edited cell lines for vaccine and biotherapeutics.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free